Outlet track record
Fierce Biotech
U.S. industry trade / center
Fierce Biotech is a B2B trade publication owned by Questex LLC, targeting professionals in the biotechnology and pharmaceutical industries with news on drug development, FDA approvals, deals, and financing. It is not a general-interest outlet and carries no consistent partisan tilt; its frame is the industry's commercial and regulatory interests. Its coverage of the Trump administration is factual and industry-focused, reporting critically on DOGE-driven FDA and NIH staffing cuts primarily through the lens of their impact on drug approvals and biomedical research.
Owned byQuestex LLC, a B2B media and events company; Questex was sold by private equity firm MidOcean Partners to Apollo Global Management in a deal signed May 2026
LeaningU.S. industry trade / center
On the administrationmostly neutral
3average bias score across 1 story
1 = straight reporting · 10 = heavily spun
1 = straight reporting · 10 = heavily spun